Table: Kobayashi Pharmaceutical -2020 group results

Kobayashi Pharmaceutical

01/02/2021 06:00

Feb 1 (Reuters)- 
          Kobayashi Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Dec 31, 2020    Dec 31, 2019   Dec 31, 2021     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          150.51          158.34         156.00                 
               (-4.9 pct)                     (+3.6 pct)               
  Operating       25.94           25.66          26.00                 
               (+1.1 pct)                     (+0.2 pct)               
  Recurring       27.73           27.85          27.80                 
               (-0.4 pct)                     (+0.3 pct)               
  Net
  Net             19.21           19.14          19.50                 
               (+0.3 pct)                     (+1.5 pct)               
  EPS          245.71 yen      244.08 yen     249.48 yen               
  Ann Div       77.00 yen       73.00 yen      79.00 yen               
  -Q2 Div       34.00 yen       33.00 yen      35.00 yen               
  -Q4 Div       43.00 yen       40.00 yen      44.00 yen               
  
  NOTE - Kobayashi Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T